Previous 10 | Next 10 |
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that Tiffany Olson has been appointed to its board of directors, effective immediately. “We are pleased...
Castle Biosciences, Inc. (CSTL) Q1 2021 Earnings Conference Call May 10, 2021, 04:30 PM ET Company Participants Camilla Zuckero - Executive Director, Investor Relations & Corporate Communications Derek Maetzold - Founder, President, and Chief Executive Officer Frank Stokes - Chief Financi...
Castle Biosciences (CSTL): Q1 GAAP EPS of -$0.17 beats by $0.06.Revenue of $22.81M (+30.9% Y/Y) beats by $6.09M.Press Release For further details see: Castle Biosciences EPS beats by $0.06, beats on revenue
Castle Biosciences (CSTL) announces a pipeline initiative to develop a genomic test aimed at predicting systemic therapy response in patients with moderate to severe psoriasis, atopic dermatitis and related conditions.The company has designed, developed and validated multiple genomic tests, i...
Q1 2021 revenues of $22.8 million, compared to $17.4 million in Q1 2020 Q1 2021 total dermatology test report volume of 4,805 Initiates 2021 Revenue Guidance of $80-83 million Q1 2021 gross margin of 87% Conference call and webcast today at 4:30 p.m. ET...
Program initiated with a 4,800-patient prospective, multi-center study Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced its innovative pipeline initia...
Castle Biosciences (NASDAQ:CSTL) is scheduled to announce Q1 earnings results on Monday, May 10th, after market close.The consensus EPS Estimate is -$0.18 and the consensus Revenue Estimate is $16.72M (-4.0% Y/Y).Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downwar...
[[ACM]], [[AEE]], [[AFRM]], [[BHF]], [[BRKS]], [[CNNE]], [[CPSI]], [[CSTL]], [[DDD]], [[EGHT]], [[ELY]], [[EVBG]], [[FGEN]], [[FOE]], [[G]], [[HALO]], [[HHC]], [[HLIO]], [[IFF]], [[INO]], [[IPAR]], [[JCOM]], [[MBI]], [[MESA]], [[MGNI]], [[MODN]], [[MRVI]], [[NCMI]], [[NHI]], [[NLOK]], [[NLS]]...
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, has been selected as the winner of the “Best New Technology Solution for Oncology” award in the fifth annual MedTech...
Study Also Shows that Patients’ Decision Regret Levels Do Not Vary According To Low- Or High-Risk DecisionDx-UM Test Result Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatmen...
News, Short Squeeze, Breakout and More Instantly...
Castle Biosciences Inc. Company Name:
CSTL Stock Symbol:
NASDAQ Market:
Castle Biosciences Inc. Website:
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Canaccord Genuity 44 th Annual Growth Conference on Tuesday, Aug. 13, 2024, at ...
Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024. Compan...